[go: up one dir, main page]

NO308736B1 - 1,2-diphenylpyrrole derivatives, pharmaceutical compositions containing them, and their use - Google Patents

1,2-diphenylpyrrole derivatives, pharmaceutical compositions containing them, and their use

Info

Publication number
NO308736B1
NO308736B1 NO971564A NO971564A NO308736B1 NO 308736 B1 NO308736 B1 NO 308736B1 NO 971564 A NO971564 A NO 971564A NO 971564 A NO971564 A NO 971564A NO 308736 B1 NO308736 B1 NO 308736B1
Authority
NO
Norway
Prior art keywords
alkyl
hydrogen
optionally substituted
pharmaceutical compositions
compositions containing
Prior art date
Application number
NO971564A
Other languages
Norwegian (no)
Other versions
NO971564D0 (en
NO971564L (en
Inventor
Tomio Kimura
Yasuo Noguchi
Akira Nakao
Keisuke Suzuki
Shigeru Ushiyama
Akihiro Kawara
Masaaki Miyamoto
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13805966&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO308736(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO971564D0 publication Critical patent/NO971564D0/en
Publication of NO971564L publication Critical patent/NO971564L/en
Publication of NO308736B1 publication Critical patent/NO308736B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compounds of formula (I) and (II): <CHEM> Äin which R is hydrogen, halogen or alkyl; R<1> is alkyl, amino or substituted amino; R<2> is optionally substituted phenyl; R<3> is hydrogen, halogen or optionally substituted alkyl; R<4> is hydrogen, optionally substituted alkyl, cycloalkyl, aryl, or aralkylÜ have valuable analgesic, anti-inflammatory, anti-pyretic and anti-allergic activities and have the ability to inhibit the production of leukotrienes and to inhibit bone resorption. They are relatively free from the side effects which generally result from the administration of compounds having these kinds of activities.
NO971564A 1996-04-05 1997-04-04 1,2-diphenylpyrrole derivatives, pharmaceutical compositions containing them, and their use NO308736B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8356296 1996-04-05

Publications (3)

Publication Number Publication Date
NO971564D0 NO971564D0 (en) 1997-04-04
NO971564L NO971564L (en) 1997-10-06
NO308736B1 true NO308736B1 (en) 2000-10-23

Family

ID=13805966

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971564A NO308736B1 (en) 1996-04-05 1997-04-04 1,2-diphenylpyrrole derivatives, pharmaceutical compositions containing them, and their use

Country Status (20)

Country Link
US (2) US5908858A (en)
EP (1) EP0799823B1 (en)
JP (1) JP3034819B2 (en)
KR (1) KR100485426B1 (en)
CN (1) CN1151126C (en)
AT (1) ATE376998T1 (en)
CA (1) CA2201812C (en)
CZ (1) CZ293048B6 (en)
DE (1) DE69738245T2 (en)
DK (1) DK0799823T3 (en)
ES (1) ES2296303T3 (en)
HU (1) HU227830B1 (en)
ID (1) ID17358A (en)
IL (1) IL120584A (en)
NO (1) NO308736B1 (en)
NZ (1) NZ314508A (en)
PT (1) PT799823E (en)
RU (1) RU2125044C1 (en)
TW (1) TW409122B (en)
ZA (1) ZA972846B (en)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09212974A (en) * 1996-01-31 1997-08-15 Mitsubishi Electric Corp Disk unit
CN1211361C (en) * 1996-03-18 2005-07-20 卫材株式会社 Carboxylic acid derivatives containing fused rings
ATE233743T1 (en) 1996-04-12 2003-03-15 Searle & Co N-((4-(5-METHYL-3-PHENYLISOXAZOLE-4- YL)PHENYL)SULPHONYLPROPYLAMIDE AND ITS SODIUM SALT AS PRO-PHARMACONE OF COX-2 INHIBITORS
US5935990A (en) * 1996-12-10 1999-08-10 G.D. Searle & Co. Substituted pyrrolyl compounds for the treatment of inflammation
EP1369415A1 (en) * 1996-12-10 2003-12-10 G.D. Searle & Co. Substituted pyrrolyl compounds for the treatment of inflammation
US6887893B1 (en) * 1997-12-24 2005-05-03 Sankyo Company, Limited Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia
RU2220721C2 (en) * 1997-12-24 2004-01-10 Санкио Компани, Лимитед Active agent for inhibiting tumor growth in mammal, treatment and/or prophylaxis tumor-associated disorders and tumor metastasis in mammals
WO1999061016A1 (en) * 1998-05-27 1999-12-02 Nippon Shinyaku Co., Ltd. Cyclooxygenase-2 inhibitors
WO2000001688A1 (en) * 1998-07-02 2000-01-13 Sankyo Company, Limited Five-membered heteroaryl compounds
RU2190399C2 (en) * 1998-07-21 2002-10-10 Санкио Компани Лимитед Preparation for treating and preventing cachexia
US6649645B1 (en) 1998-12-23 2003-11-18 Pharmacia Corporation Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
US7122666B2 (en) 1999-07-21 2006-10-17 Sankyo Company, Limited Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
ATE312820T1 (en) * 1999-10-28 2005-12-15 Trine Pharmaceuticals Inc PUMP INHIBITORS FOR DRUG RELEASE
PT1175214E (en) 1999-12-08 2005-04-29 Pharmacia Corp COMPOSITIONS OF CYCLE-OXYGENASE-2 INHIBITOR WITH A QUICK START OF ITS THERAPEUTIC EFFECT
US6376489B1 (en) * 1999-12-23 2002-04-23 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors
CA2393724A1 (en) 1999-12-23 2001-06-28 Nitromed, Inc. Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
US6372777B1 (en) * 1999-12-23 2002-04-16 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors
RU2198170C2 (en) * 1999-12-27 2003-02-10 Санкио Компани, Лимитед Derivatives of pyrrole, pharmaceutical composition based on thereof and method of treatment
US6440994B1 (en) * 2000-03-29 2002-08-27 Richard J. Sanders, Jr. Method of treating acne
MY137736A (en) 2001-04-03 2009-03-31 Pharmacia Corp Reconstitutable parenteral composition
WO2002080974A1 (en) * 2001-04-04 2002-10-17 Sankyo Company, Limited Novel medicinal use of cytokine production inhibitor
US20030105144A1 (en) 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
US6673818B2 (en) 2001-04-20 2004-01-06 Pharmacia Corporation Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
AR038957A1 (en) 2001-08-15 2005-02-02 Pharmacia Corp COMBINATION THERAPY FOR CANCER TREATMENT
GB0212785D0 (en) * 2002-05-31 2002-07-10 Glaxo Group Ltd Compounds
WO2004002420A2 (en) * 2002-06-28 2004-01-08 Nitromed, Inc. Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
JP4458514B2 (en) * 2002-07-18 2010-04-28 第一三共株式会社 Method for producing high purity enamines
KR100988750B1 (en) * 2002-08-20 2010-10-20 상꾜 가부시키가이샤 Method for producing γ-keto acetals
JP4601274B2 (en) * 2002-08-20 2010-12-22 第一三共株式会社 Method for producing γ-ketoacetals
GB0225548D0 (en) 2002-11-01 2002-12-11 Glaxo Group Ltd Compounds
RU2308264C2 (en) * 2002-12-02 2007-10-20 Каунсел Оф Сайнтифик Энд Индастриал Рисерч Method for preventing and/or treating asthma due to applying pbpb
EP1572173B1 (en) 2002-12-13 2010-04-28 Warner-Lambert Company LLC Alpha-2-delta ligand to treat lower urinary tract symptoms
US20060275503A1 (en) * 2003-05-07 2006-12-07 Nordic Bone A/S Combination treatment with strontium for the prophylaxis and/or treatment of cartilage and/or bone conditions
PL1534305T3 (en) * 2003-05-07 2007-03-30 Osteologix As Treating cartilage / bone conditions with water-soluble strontium salts
GB0328024D0 (en) * 2003-12-03 2004-01-07 Glaxo Group Ltd Compounds
JP2007518788A (en) 2004-01-22 2007-07-12 ファイザー・インク Triazole derivatives that inhibit the antagonist activity of vasopressin
EP1928827B1 (en) * 2005-09-27 2012-08-22 Myriad Genetics, Inc. Pyrrole derivatives as therapeutic compounds
WO2007084853A2 (en) * 2006-01-13 2007-07-26 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods for inhibiting osteoclastogenesis
AU2007265116A1 (en) * 2006-06-27 2008-01-03 Abbott Laboratories Pyrrole derivatives and their methods of use
EP1889617A1 (en) * 2006-07-11 2008-02-20 Freie Universität Berlin Triphenyl modified 5-membered heterocycles and their use as anticancer and antiflammatory agents
US7906551B2 (en) 2006-08-03 2011-03-15 Rottapharm S.P.A. 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective COX-2 inhibitors
TW200812950A (en) * 2006-08-18 2008-03-16 Daiichi Sankyo Co Ltd Process for producing acetophenone bromide
CA2662870A1 (en) * 2006-09-07 2008-03-13 Myriad Genetics, Inc. Therapeutic compounds for diseases and disorders
CA2673545A1 (en) 2006-12-22 2008-07-03 Recordati Ireland Limited Combination therapy of lower urinary tract disorders with .alpha.2.delta. ligands and nsaids
WO2008091530A2 (en) * 2007-01-19 2008-07-31 Mallinckrodt Inc. Diagnostic and therapeutic cyclooxygenase-2 binding ligands
CA2692977A1 (en) * 2007-07-12 2009-01-15 Tragara Pharmaceuticals, Inc. Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders
EP2175722A4 (en) * 2007-07-12 2010-08-25 Tragara Pharmaceuticals Inc PATIENT SELECTION AND THERAPEUTIC METHODS USING PROSTAGLANDIN METABOLISM MARKERS
EP2205077A4 (en) * 2007-09-24 2010-12-29 Tragara Pharmaceuticals Inc Therapies for treating cancer using combinations of cox-2 inhibitors and anti-her2(erbb2) antibodies or combinations of cox-2 inhibitors and her2(erbb2) receptor tyrosine kinase inhibitors
EP2284154A1 (en) * 2009-07-29 2011-02-16 Argon Pharma S.L. Antitumor 1,2-diphenylpyrrole compounds and their preparation process
ES2372769B1 (en) * 2010-07-08 2012-12-03 Universitat De Barcelona METIL SULFON FENIL WITH ANTI-FLAMMING ACTIVITY AND ANTITUMORAL ACTIVITY.
SG193387A1 (en) * 2011-03-31 2013-10-30 Lupin Ltd Pyrrole derivatives as nicotinic acetylcholine receptor modulators for use in the treatment of neurodegenerative disorders such as alzheimer's and parkinson's disease
WO2019015974A1 (en) 2017-07-18 2019-01-24 Firmenich Sa Cyclamen odorant
IL305573A (en) 2021-03-15 2023-10-01 Saul Yedgar Hyaluronic acid conjugated with dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment or suppression of inflammatory diseases

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1356901A (en) 1958-03-13 1964-04-03 Novel aminoetheroxides, aminothioethers and aminoesters derived from pyrrole, and their preparation process
US3168531A (en) 1963-06-12 1965-02-02 Parke Davis & Co 1-aryl-5-(p-lower alkoxyphenyl)-pyrrole-2-propionic acid compounds
US3168532A (en) 1963-06-12 1965-02-02 Parke Davis & Co 1, 5-diarylpyrrole-2-propionic acid compounds
US3285931A (en) 1964-12-21 1966-11-15 Union Carbide Corp Preparation of substituted pyrrole derivatives
US3427305A (en) * 1966-11-01 1969-02-11 Searle & Co 5 - ((halo/alkoxy)phenyl) - 1 - (p - sulfonamido(phenyl/benzyl)) - 2 - pyrrolepropionic acids
US3551571A (en) 1967-05-19 1970-12-29 Endo Lab Methods for reducing pain,reducing fever and alleviating inflammatory syndromes with heteroaromatic pyrrol-3-yl ketones
GB1271082A (en) 1968-05-07 1972-04-19 Wyeth John & Brother Ltd Furan, pyrrole and thiophene derivatives
FR2054474A2 (en) 1969-07-09 1971-04-23 Innothera Lab Sa Analgesic, antiinflammatory 1-phenyl-2, 5-di
DE1938904A1 (en) * 1968-08-02 1970-02-05 Innothera Lab Sa 1-phenylpyrroles
US3714232A (en) 1969-06-25 1973-01-30 Merck & Co Inc 5-arylphenyl sulfonic acids
DE2419970C3 (en) 1974-04-25 1980-06-12 Hoechst Ag, 6000 Frankfurt 3- <1-Pyrrolidinyl) -4-phenoxy-5sulfamoylbenzoic acid and process for its preparation
US4093735A (en) 1974-04-25 1978-06-06 Hoechst Aktiengesellschaft 5-Sulfamoylbenzoic acid derivatives carrying a heterocyclic substituent
CH628622A5 (en) 1976-12-24 1982-03-15 Ciba Geigy Ag METHOD FOR PRODUCING NEW 3-SULFAMOYLBENZOESAIDS SUBSTITUTED IN 4-POSITION.
US4335136A (en) 1980-04-18 1982-06-15 E. I. Du Pont De Nemours And Company Anti-inflammatory 4,5-diaryl-α-(polyfluoroalkyl)-1H-pyrrole-2-methanamines
DE3309355A1 (en) 1983-03-16 1984-09-27 Basf Ag, 6700 Ludwigshafen METHOD FOR PRODUCING PYRROL
US4694018A (en) * 1985-11-29 1987-09-15 G. D. Serale & Co. Substituted 1,5-diphenyl-2-pyrrolepropionic acids and derivatives
US4792568A (en) 1986-04-14 1988-12-20 Rorer Pharmaceutical Corporation Aryl pyrroles as useful antiallergy compounds
NO881411L (en) 1987-04-14 1988-10-17 Bayer Ag SUBSTITUTED PYROLES.
US5010098A (en) * 1987-07-29 1991-04-23 American Cyanamid Company Arylpyrrole insecticidal acaricidal and nematicidal agents and methods for the preparation thereof
US5455263A (en) * 1987-07-29 1995-10-03 American Cyanamid Company Methods for the control and the protection of warm-blooded animals against infestation and infection by helminths, acarids and arthropod endo- and ectoparasites
DE3727114A1 (en) 1987-08-14 1989-02-23 Basf Ag METHOD FOR PRODUCING PYRROL
CA1334975C (en) 1987-11-13 1995-03-28 James H. Holms Furan and pyrrole containing lipoxygenase inhibiting compounds
AU641905B2 (en) * 1988-12-09 1993-10-07 Rhone-Poulenc Agrochimie 1-substituted-phenyl pyrrole derivatives as insecticides and methods for their production
US5096919A (en) 1989-01-05 1992-03-17 Ciba-Geigy Corporation Pyrrolylphenyl-substituted hydroxamic acid derivatives
DE3903993A1 (en) * 1989-02-10 1990-08-16 Basf Ag DIARYL SUBSTITUTED HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND MEDICINAL PRODUCTS THEREOF
JPH05501103A (en) 1989-06-26 1993-03-04 ザ・リサーチ・ファウンデーション・オヴ・ステイト・ユニヴァーシティ・オヴ・ニューヨーク Bis-acyloxymethyl derivative
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
DD298912A5 (en) 1989-11-17 1992-03-19 �������@������������@��k�� PROCESS FOR THE PREPARATION OF 3-AMINOPYRROLES
ZA915371B (en) * 1990-07-17 1993-03-31 Lilly Co Eli Antitumor compositions and methods of treatment
US5157047A (en) * 1990-10-18 1992-10-20 American Cyanamid Company Bis- and tris(trifluoromethyl)arylpyrrole insecticidal and acaricidal agents
DE4036706A1 (en) 1990-11-17 1992-05-21 Hoechst Ag METHOD FOR THE TREATMENT OF CARDIALS AND VASCULAR HYPERTROPHY AND HYPERPLASIA
US5128485A (en) 1990-12-17 1992-07-07 American Cyanamid Company Synthesis of 2-aryl-5-(trifluoromethyl)pyrroles useful as pesticidal agents and as intermediates for the preparation of said agents
US5118816A (en) * 1990-12-26 1992-06-02 American Cyanamid Company 2-aryl-5-(trifluoromethyl)-2-pyrroline compounds useful in the manufacture of insecticidal, nematocidal and acaricidal arylpyrroles
US5144041A (en) 1990-12-26 1992-09-01 American Cyanamid Company Process for the preparation of 2-aryl-1-substituted-5-(trifluoromethyl) pyrrole compounds useful as insecticidal, acaricidal and nematocidal agents and as intermediates for the manufacture of said agents
US5254713A (en) 1991-04-09 1993-10-19 Nihon Bayer Agrochem K.K. 2- and 3-chloropyrroles and process for preparing the same
JPH051027A (en) * 1991-04-09 1993-01-08 Nippon Bayeragrochem Kk New 2-or 3-chloropyrroles and production thereof
YU8592A (en) 1991-08-28 1994-06-10 Flumroc Ag. PROCEDURE AND DEVICE FOR MAKING MINERAL FIBER SLABS USED AS A WALL COATING BRACKET
US5928635A (en) 1994-12-07 1999-07-27 Schmidt; Karlheinz Process for producing active agent complexes
ES2111288T3 (en) * 1993-01-15 1998-03-01 Searle & Co NEW 3,4-DIARYL THIOPHENES AND ANALOGS OF THE SAME USEFUL AS ANTI-INFLAMMATORY AGENTS.
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
US5474995A (en) 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5344991A (en) * 1993-10-29 1994-09-06 G.D. Searle & Co. 1,2 diarylcyclopentenyl compounds for the treatment of inflammation
US5434178A (en) * 1993-11-30 1995-07-18 G.D. Searle & Co. 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation
ES2180233T3 (en) * 1993-11-30 2003-02-01 Searle & Co PIRAZOLIL BENCENOSULFONAMIDS REPLACED FOR USE IN THE TREATMENT OF INFLAMMATION.
US5418254A (en) * 1994-05-04 1995-05-23 G. D. Searle & Co. Substituted cyclopentadienyl compounds for the treatment of inflammation
US5496845A (en) 1994-05-25 1996-03-05 American Cyanamid Co. Suspension concentrate compositions of arylpyrrole insecticidal and acaricidal agents
US5486534A (en) * 1994-07-21 1996-01-23 G. D. Searle & Co. 3,4-substituted pyrazoles for the treatment of inflammation
JPH10504542A (en) * 1994-07-27 1998-05-06 ジー．ディー．サール アンド カンパニー Substituted thiazole compounds for treating inflammation
US5616601A (en) * 1994-07-28 1997-04-01 Gd Searle & Co 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
US5620999A (en) * 1994-07-28 1997-04-15 Weier; Richard M. Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
US5521213A (en) 1994-08-29 1996-05-28 Merck Frosst Canada, Inc. Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
GB2294879A (en) 1994-10-19 1996-05-15 Merck & Co Inc Cylcooxygenase-2 Inhibitors
JP2636819B2 (en) * 1994-12-20 1997-07-30 日本たばこ産業株式会社 Oxazole-based heterocyclic aromatic compounds
JP3267300B2 (en) * 1995-02-13 2002-03-18 ジー．ディー．サール アンド カンパニー Substituted isoxazoles for the treatment of inflammation
US5643933A (en) 1995-06-02 1997-07-01 G. D. Searle & Co. Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US5700816A (en) 1995-06-12 1997-12-23 Isakson; Peter C. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
DE69635048T2 (en) 1995-06-12 2006-02-16 G.D. Searle & Co. MEDIUM, CONTAINING A CYCLOOXYGENASE-2 INHIBITOR AND A 5-LIPOXYGENASE INHIBITOR
US5792778A (en) 1995-08-10 1998-08-11 Merck & Co., Inc. 2-substituted aryl pyrroles, compositions containing such compounds and methods of use
EP0859642A2 (en) 1995-10-17 1998-08-26 G.D. Searle & Co. Method of detecting cyclooxygenase-2
EP0983265A4 (en) 1996-02-01 2001-10-17 Smithkline Beecham Corp Endothelin receptor antagonists
ATE233743T1 (en) * 1996-04-12 2003-03-15 Searle & Co N-((4-(5-METHYL-3-PHENYLISOXAZOLE-4- YL)PHENYL)SULPHONYLPROPYLAMIDE AND ITS SODIUM SALT AS PRO-PHARMACONE OF COX-2 INHIBITORS
US5935990A (en) 1996-12-10 1999-08-10 G.D. Searle & Co. Substituted pyrrolyl compounds for the treatment of inflammation
US5972986A (en) 1997-10-14 1999-10-26 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
US6025353A (en) 1997-11-19 2000-02-15 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
DE19812059C1 (en) * 1998-03-19 1999-09-23 Wella Ag Diaminobenzene derivatives and hair dye containing these diaminobenzene derivatives
US8887786B2 (en) * 2011-03-07 2014-11-18 Hunter Douglas Inc. Control for movable rail

Also Published As

Publication number Publication date
US5908858A (en) 1999-06-01
HUP9700709A3 (en) 2000-04-28
CZ103597A3 (en) 1997-10-15
AU710380B2 (en) 1999-09-16
HU227830B1 (en) 2012-05-02
DK0799823T3 (en) 2008-03-03
ZA972846B (en) 1997-11-04
CN1151126C (en) 2004-05-26
CA2201812A1 (en) 1997-10-05
CA2201812C (en) 2007-09-18
JPH09323971A (en) 1997-12-16
IL120584A0 (en) 1997-08-14
DE69738245D1 (en) 2007-12-13
AU1665397A (en) 1997-10-09
KR100485426B1 (en) 2005-10-12
NO971564D0 (en) 1997-04-04
ID17358A (en) 1997-12-24
CN1168372A (en) 1997-12-24
NZ314508A (en) 1999-06-29
HK1003268A1 (en) 1998-10-23
JP3034819B2 (en) 2000-04-17
IL120584A (en) 2003-10-31
ATE376998T1 (en) 2007-11-15
RU2125044C1 (en) 1999-01-20
EP0799823B1 (en) 2007-10-31
EP0799823A1 (en) 1997-10-08
TW409122B (en) 2000-10-21
HUP9700709A2 (en) 1999-05-28
DE69738245T2 (en) 2008-08-14
NO971564L (en) 1997-10-06
USRE39420E1 (en) 2006-12-05
CZ293048B6 (en) 2004-01-14
ES2296303T3 (en) 2008-04-16
PT799823E (en) 2008-01-15
HU9700709D0 (en) 1997-05-28
KR970069985A (en) 1997-11-07

Similar Documents

Publication Publication Date Title
NO308736B1 (en) 1,2-diphenylpyrrole derivatives, pharmaceutical compositions containing them, and their use
ATE260255T1 (en) 5-OXO-PYRROLIDINE-2-CARBONIC ACID HYDROXAMIDE DERIVATIVES
IS6257A (en) Cell adhesion blocks
NO922147L (en) HETEROCYCLIC DERIVATIVES
DK0850926T3 (en) Difluoro-prostaglandin derivatives and their use
DE69820248D1 (en) PYRROLIDIN DERIVATIVES HAVING A PHOSPHOLIPASE A2 INHIBITING EFFECT
DE68914292D1 (en) Composition for the treatment of ischemic disorders in organs.
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
ATE70530T1 (en) ANTI-INFLAMMATORY ARYL DERIVATIVES.
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
DE60002558D1 (en) Derivatives of phosphonic acid to inhibit carboxypeptidase B
DK183789A (en) 2-ALKYL-3-BENZOYLBENZOFURANES AND MEDICINES CONTAINING THESE
DE69828197D1 (en) AMID DERIVATIVES FOR THE TREATMENT OF NEURODEEGENERATIVE DISORDERS OF THE NETWORK
DK0514942T3 (en) Novel benzopyran derivatives and processes for their preparation
EA200101109A1 (en) DERIVATIVES 1-TRIFTOROMETHYL-4-HYDROXY-7-PIPERIDINYL-AMINOMETHILKHROMAN
DE69827706D1 (en) 5- (Heteroaryl) alkyl) -3-oxo-pyrido (1,2-a) benzimidazole-4-carboxamide (PBI) derivatives for the treatment of disorders of the central nervous system
ATE229804T1 (en) ANTIBACTERIAL CARBAPENEMS, COMPOSITIONS AND METHODS OF TREATMENT
TH23930A (en) Weed killer

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees